AVAN - details herein.
quote.yahoo.com
Currently #1 gainer with volume 33 times 65-day average. Chart suggests gap over the weekend. Especially likely if the news gets around. Good play at close? Definitely one to watch if their drug comes through.
Any thoughts ?
Recent headlines :
Avant Immunotherapeutics Claims 89% Success For Rotavirus Vaccine, Dow Jones Online News, 07/23/1999, 11:49, 302 words
New vaccine prevents childhood diarrhoea - study, Reuters, 07/23/1999, 00:31, 412 words
New compound may help limit stroke damage - study, Reuters, 07/22/1999, 21:19, 684 words
Clinical Results With AVANT Rotavirus Vaccine Demonstrate Nearly 90% Protection in Young Children, PR Newswire, 07/22/1999, 18:47, 1098 words
AVANT'S Hybrid Complement-Selectin Inhibitor, TP20, Significantly Limits Brain Damage in an Animal Model of Ischemic Stroke, PR Newswire, 07/22/1999, 14:17, 1105 words
AVANT Announces Novartis Exercise of Option to License TP10 in the Field of Transplantation, PR Newswire, 07/19/1999, 08:47, 940 words
AVANT Immunotherapeutics Appoints Alistair Wheeler as Vice President, Medical Affairs, PR Newswire, 07/14/1999, 11:43, 755 words
AVANT Achieves Major Milestone in Rotavirus Vaccine Program With SmithKline Beecham, PR Newswire, 06/21/1999, 09:44, 1044 words
AVANT Begins Human Clinical Trials of Novel Atherosclerosis Vaccine, PR Newswire, 06/21/1999, 09:38, 770 words
AVANT Immunotherapeutics Reports First Quarter 1999 Financial Results, PR Newswire, 05/13/1999, 14:01, 881 words |
